BioTrends: M&A Malaise

by Desiree de Myer, BioPharm International Despite market conditions favorable to merger and acquisition activity, a frenzy of consolidations still hasn't taken place.

Related Content:

Guest Interview: A Strong Dose of Reality: Visiting with Cynthia Robbins-Roth

Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablement

Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detection